Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

Journal of the American College of Cardiology

Volumn 63, Issue 22, 2014, Pages 2356-2362

  Pizarro, Gonzalo ^a,b   Fernández Friera, Leticia ^a,c   Fuster, Valentin ^a,d   Fernández Jiménez, Rodrigo ^a,e   García Ruiz, José M ^a,f   García Álvarez, Ana ^a,g   Mateos, Alonso ^h   Barreiro, María V ⁱ   Escalera, Noemí ^a   Rodriguez, Maite D ^a   De Miguel, Antonio ^j   García Lunar, Inés ^a,b,k   Parra Fuertes, Juan J ^l   Sánchez González, Javier ^a,m   Pardillos, Luis ^h   Nieto, Beatriz ^j   Jiménez, Adriana ⁿ   Abejón, Raquel ^h   Bastante, Teresa ^o   Martínez De Vega, Vicente ^b   Cabrera, José A ^b   López Melgar, Beatriz ^a,l   Guzman, Gabriela ^a,p   García Prieto, Jaime ^a   Mirelis, Jesús G ^a,k   Zamorano, José Luis ^e   Albarrán, Agustín ^l   Goicolea, Javier ^k   Escaned, Javier ^a,e   Pocock, Stuart ^a,q   Iñiguez, Andrés ^j   Fernández Ortiz, Antonio ^a,e   Sánchez Brunete, Vicente ^h   Macaya, Carlos ^e   Ibanez, Borja ^a,e   more..

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^c Montepríncipe University Hospital   (Spain)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h Servicio de Urgencia Medica de Madrid SUMMA 112   (Spain)

ⁱ Servicio de Emergencia Medica 061 de Galicia Sur   (Spain)

^j UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^k HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^l HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^m PHILIPS HEALTHCARE   (United States)

ⁿ UNIVERSITY OF LEÓN   (Spain)

^o HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^p HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^q LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

beta adrenergic receptors; heart failure; ICD; infarct size; LVEF; magnetic resonance imaging; metoprolol; myocardial infarction; PCI; STEMI

Indexed keywords

METOPROLOL; METOPROLOL TARTRATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE HEART INFARCTION; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; EARLY INTERVENTION; FEMALE; MALE; TREATMENT DURATION; TREATMENT OUTCOME;

BETA-ADRENERGIC RECEPTORS; HEART FAILURE; ICD; INFARCT SIZE; LVEF; MAGNETIC RESONANCE IMAGING; METOPROLOL; MYOCARDIAL INFARCTION; PCI; STEMI;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; EARLY MEDICAL INTERVENTION; HUMANS; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; SINGLE-BLIND METHOD; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84902077740     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.014     Document Type: Article

References (29)

1. P.T. O'Gara, F.G. Kushner, and D.D. Ascheim et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 e78 e140
2. P.G. Steg, S.K. James, and D. Atar et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
3. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
4. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
5. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Eur Heart J 33 2012 1787 1847
6. E. Larose, J. Rodes-Cabau, and P. Pibarot et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction: traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance J Am Coll Cardiol 55 2010 2459 2469
7. G. Heusch Cardioprotection: chances and challenges of its translation to the clinic Lancet 381 2013 166 175
8. R.A. Kloner Current state of clinical translation of cardioprotective agents for acute myocardial infarction Circ Res 113 2013 451 463
9. B. Ibanez, C. Macaya, and V. Sanchez-Brunete et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 2013 1495 1503
10. B. Ibanez, V. Fuster, and C. Macaya et al. Study design for the "Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction Am Heart J 164 2012 473 480.e475
11. C.M. Kramer, M.J. Budoff, and Z.A. Fayad et al. ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training J Am Coll Cardiol 50 2007 1097 1114
12. R.J. Burns, R.J. Gibbons, and Q. Yi et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis J Am Coll Cardiol 39 2002 30 36
13. A.D. Sloth, M.R. Schmidt, and K. Munk et al. Improved long-term clinical outcomes in patients with st-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention Eur Heart J 35 2014 168 175
14. G.W. Stone, B. Witzenbichler, and J. Godlewski et al. Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial Circ Cardiovasc Interv 6 2013 527 534
15. M.T. Roe, J.C. Messenger, and W.S. Weintraub et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention J Am Coll Cardiol 56 2010 254 263
16. M. Buxton, N. Caine, and D. Chase et al. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context Health Technol Assess 10 2006 iii-iv, ix-xi, 1-164
17. J. Bryant, H. Brodin, E. Loveman, and A. Clegg Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation Int J Technol Assess Health Care 23 2007 63 70
18. A. Lubinski, A. Bissinger, and L. Boersma et al. Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries - data from the European Heart Rhythm Association White Book Europace 13 2011 654 662
19. M.A. Hlatky, and D.B. Mark The high cost of implantable defibrillators Eur Heart J 28 2007 388 391
20. D.O. Abegunde, C.D. Mathers, T. Adam, M. Ortegon, and K. Strong The burden and costs of chronic diseases in low-income and middle-income countries Lancet 370 2007 1929 1938
21. N.M. LaPointe, S.M. Al-Khatib, and J.P. Piccini et al. Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction Circ Cardiovasc Qual Outcomes 4 2011 146 151
22. J.A. Udell, D.N. Juurlink, and A. Kopp et al. Inequitable distribution of implantable cardioverter defibrillators in Ontario Int J Technol Assess Health Care 23 2007 354 361
23. A.F. Hernandez, G.C. Fonarow, and L. Liang et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 2007 1525 1532
24. G.C. Fonarow, C.W. Yancy, and N.M. Albert et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail 1 2008 98 106
25. K. Narayanan, K. Reinier, and A. Uy-Evanado et al. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community Circulation 128 2013 1733 1738
26. T. Baks, R.J. van Geuns, and E. Biagini et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics J Am Coll Cardiol 47 2006 40 44
27. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
28. Z.M. Chen, H.C. Pan, and Y.P. Chen et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
29. R.J. Gibbons, U.S. Valeti, P.A. Araoz, and A.S. Jaffe The quantification of infarct size J Am Coll Cardiol 44 2004 1533 1542